BMC Cancer 2007, 7:187 http://www.biomedcentral.com/1471-2407/7/187 2. Kerkela E, Saarialho-Kere U: Matrix metalloproteinases in tumor progression: focus on basal and squamous cell skin cancer. Experimental dermatology 2003, 12(2):109-125. 3. Impola U, Uitto VJ, Hietanen J, Hakkinen L, Zhang L, Larjava H, Isaka K, Saarialho-Kere U: Differential expression of matrilysin-1 (MMP-7), 92 kD gelatinase (MMP-9), and metalloelastase (MMP-12) in oral verrucous and squamous cell cancer. The Journal of pathology 2004, 202(1):14-22. 4. Brinckerhoff CE, Rutter JL, Benbow U: Interstitial collagenases as markers of tumor progression. Clin Cancer Res 2000, 6(12):4823-4830. 5. Nagata M, Fujita H, Ida H, Hoshina H, Inoue T, Seki Y, Ohnishi M, Ohyama T, Shingaki S, Kaji M, et al.: Identification of potential biomarkers of lymph node metastasis in oral squamous cell carcinoma by cDNA microarray analysis. International journal of cancer 2003, 106(5):683-689. 6. Murray GI, Duncan ME, O'Neil P, McKay JA, Melvin WT, Fothergill JE: Matrix metalloproteinase-1 is associated with poor progno- sis in oesophageal cancer. The Journal of pathology 1998, 185(3):256-261. 7. Shiozawa J, Ito M, Nakayama T, Nakashima M, Kohno S, Sekine I: Expression of matrix metalloproteinase-1 in human colorec- tal carcinoma. Mod Pathol 2000, 13(9):925-933. 8. Shima I, Sasaguri Y, Kusukawa J, Yamana H, Fujita H, Kakegawa T, Morimatsu M: Production of matrix metalloproteinase-2 and metalloproteinase-3 related to malignant behavior of esophageal carcinoma. A clinicopathologic study. Cancer 1992, 70(12):2747-2753. 9. Kurahara S, Shinohara M, Ikebe T, Nakamura S, Beppu M, Hiraki A, Takeuchi H, Shirasuna K: Expression of MMPS, MT-MMP, and TIMPs in squamous cell carcinoma of the oral cavity: corre- lations with tumor invasion and metastasis. Head & neck 1999, 21(7):627-638. 10. Ye S: Polymorphism in matrix metalloproteinase gene pro- moters: implication in regulation of gene expression and sus- ceptibility of various diseases. Matrix Biol 2000, 19(7):623-629. 11. Rutter JL, Mitchell TI, Buttice G, Meyers J, Gusella JF, Ozelius LJ, Brinckerhoff CE: A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter creates an Ets binding site and augments transcription. Cancer research 1998, 58(23):5321-5325. 12. Ye S, Eriksson P, Hamsten A, Kurkinen M, Humphries SE, Henney AM: Progression of coronary atherosclerosis is associated with a common genetic variant of the human stromelysin-1 promoter which results in reduced gene expression. The Jour- nal of biological chemistry 1996, 271(22):13055-13060. 13. Hinoda Y, Okayama N, Takano N, Fujimura K, Suehiro Y, Hamanaka Y, Hazama S, Kitamura Y, Kamatani N, Oka M: Association of func- tional polymorphisms of matrix metalloproteinase (MMP)-1 and MMP-3 genes with colorectal cancer. International journal of cancer 2002, 102(5):526-529. 14. Kanamori Y, Matsushima M, Minaguchi T, Kobayashi K, Sagae S, Kudo R, Terakawa N, Nakamura Y: Correlation between expression of the matrix metalloproteinase-1 gene in ovarian cancers and an insertion/deletion polymorphism in its promoter region. Cancer research 1999, 59(17):4225-4227. 15. Zhu Y, Spitz MR, Lei L, Mills GB, Wu X: A single nucleotide poly- morphism in the matrix metalloproteinase-1 promoter enhances lung cancer susceptibility. Cancer research 2001, 61(21):7825-7829. 16. Nishioka Y, Kobayashi K, Sagae S, Ishioka S, Nishikawa A, Matsushima M, Kanamori Y, Minaguchi T, Nakamura Y, Tokino T, et al.: A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter in endometrial carcinomas. Jpn J Cancer Res 2000, 91(6):612-615. 17. Hirata H, Naito K, Yoshihiro S, Matsuyama H, Suehiro Y, Hinoda Y: A single nucleotide polymorphism in the matrix metallopro- teinase-1 promoter is associated with conventional renal cell carcinoma. International journal of cancer 2003, 106(3):372-374. 18. Hashimoto T, Uchida K, Okayama N, Imate Y, Suehiro Y, Hamanaka Y, Ueyama Y, Shinozaki F, Yamashita H, Hinoda Y: Association of matrix metalloproteinase (MMP)-1 promoter polymor- phism with head and neck squamous cell carcinoma. Cancer letters 2004, 211(1):19-24. 19. Ghilardi G, Biondi ML, Caputo M, Leviti S, DeMonti M, Guagnellini E, Scorza R: A single nucleotide polymorphism in the matrix metalloproteinase-3 promoter enhances breast cancer sus- ceptibility. Clin Cancer Res 2002, 8(12):3820-3823. 20. Sutinen M, Kainulainen T, Hurskainen T, Vesterlund E, Alexander JP, Overall CM, Sorsa T, Salo T: Expression of matrix metallopro- teinases (MMP-1 and -2) and their inhibitors (TIMP-1, -2 and -3) in oral lichen planus, dysplasia, squamous cell carcinoma and lymph node metastasis. British journal of cancer 1998, 77(12):2239-2245. 21. Jordan RC, Macabeo-Ong M, Shiboski CH, Dekker N, Ginzinger DG, Wong DT, Schmidt BL: Overexpression of matrix metallopro- teinase-1 and -9 mRNA is associated with progression of oral dysplasia to cancer. Clin Cancer Res 2004, 10(19):6460-6465. 22. Lin SC, Chung MY, Huang JW, Shieh TM, Liu CJ, Chang KW: Corre- lation between functional genotypes in the matrix metallo- proteinases-1 promoter and risk of oral squamous cell carcinomas. J Oral Pathol Med 2004, 33(6):323-326. 23. Cao ZG, Li CZ: A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter enhances oral squa- mous cell carcinoma susceptibility in a Chinese population. Oral oncology 2006, 42(1):32-38. 24. Vairaktaris E, Yapijakis C, Derka S, Serefoglou Z, Vassiliou S, Nkenke E, Ragos V, Vylliotis A, Spyridonidou S, Tsigris C, et al.: Association of matrix metalloproteinase-1 (-1607 1G/2G) polymorphism with increased risk for oral squamous cell carcinoma. Antican- cer research 2007, 27(1A):459-464. 25. Llewellyn CD, Johnson NW, Warnakulasuriya KA: Risk factors for squamous cell carcinoma of the oral cavity in young people – a comprehensive literature review. Oral oncology 2001, 37(5):401-418. 26. Kuwano H, Kato H, Miyazaki T, Fukuchi M, Masuda N, Nakajima M, Fukai Y, Sohda M, Kimura H, Faried A: Genetic alterations in esophageal cancer. Surgery today 2005, 35(1):7-18. 27. Herrero R, Castellsague X, Pawlita M, Lissowska J, Kee F, Balaram P, Rajkumar T, Sridhar H, Rose B, Pintos J, et al.: Human papilloma- virus and oral cancer: the International Agency for Research on Cancer multicenter study. Journal of the National Cancer Insti- tute 2003, 95(23):1772-1783. 28. Llewellyn CD, Johnson NW, Warnakulasuriya KA: Risk factors for oral cancer in newly diagnosed patients aged 45 years and younger: a case-control study in Southern England. J Oral Pathol Med 2004, 33(9):525-532. 29. Lee WH, Bookstein R, Hong F, Young LJ, Shew JY, Lee EY: Human retinoblastoma susceptibility gene: cloning, identification, and sequence. Science 1987, 235(4794):1394-1399. 30. Wong P, Verselis SJ, Garber JE, Schneider K, DiGianni L, Stockwell DH, Li FP, Syngal S: Prevalence of early onset colorectal cancer in 397 patients with classic Li-Fraumeni syndrome. Gastroen- terology 2006, 130(1):73-79. 31. Nishisho I, Nakamura Y, Miyoshi Y, Miki Y, Ando H, Horii A, Koyama K, Utsunomiya J, Baba S, Hedge P: Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. Science 1991, 253(5020):665-669. 32. Golshan M, Miron A, Nixon AJ, Garber JE, Cash EP, Iglehart JD, Harris JR, Wong JS: The prevalence of germline BRCA1 and BRCA2 mutations in young women with breast cancer undergoing breast-conservation therapy. American journal of surgery 2006, 192(1):58-62. 33. Huang WS, Tang R, Lin PY, Changchien CR, Chen JS, Chiang JM, Yeh CY, Wang JY, Hsieh LL: Impact of the cyclin D1 A870G poly- morphism on susceptibility to sporadic colorectal cancer in Taiwan. Diseases of the colon and rectum 2006, 49(5):602-608. 34. Zheng Y, Shen H, Sturgis EM, Wang LE, Eicher SA, Strom SS, Frazier ML, Spitz MR, Wei Q: Cyclin D1 polymorphism and risk for squamous cell carcinoma of the head and neck: a case-con- trol study. Carcinogenesis 2001, 22(8):1195-1199. 35. Liang G, Xing D, Miao X, Tan W, Yu C, Lu W, Lin D: Sequence var- iations in the DNA repair gene XPD and risk of lung cancer in a Chinese population. International journal of cancer 2003, 105(5):669-673. 36. Hu Z, Shao M, Yuan J, Xu L, Wang F, Wang Y, Yuan W, Qian J, Ma H, Wang Y, et al.: Polymorphisms in DNA damage binding pro- tein 2 (DDB2) and susceptibility of primary lung cancer in the Chinese: a case-control study. Carcinogenesis 2006, 27(7):1475-1480. 37. Hu Z, Huo X, Lu D, Qian J, Zhou J, Chen Y, Xu L, Ma H, Zhu J, Wei Q, et al.: Functional polymorphisms of matrix metalloprotei- Page 8 of 9 (page number not for citation purposes)